"anesthetic depth" or "hypnotic state." Algorithms will have to be developed to avoid misinterpretation of the clinical state of the brain. 6 . Bischoff P, Kochs were given preoperatively. Standard monitors were used. Premedication included glycopyrrolate, midazolam, and fentanyl. The airway was anesthetized locally with a solution of procaine and epinephrine for the first procedure and with bupivacaine and epinephrine and inhaled bupivacaine in albuterol for the second surgery. Nasotracheal fiberoptic intubation, with a No. 6.5 reinforced tube, was then performed uneventfully during propofol sedation (75-100 mg * kg-' . min-').
Anesthesia was induced with 2 mg/kg and maintained with 140 -180 mg . kg-' . min-' propofol. Vecuronium was used for paralysis, and the lungs were ventilated with 35-40% 0, in N,O. Dextrose was continued intraoperatively, and normothermia was maintained. Clindamycin was also given intravenously, and bupivacaine and betdmethasone were injected into the joint by the surgeon. After completion of surgery, neostigmine and glycopyrrolate were given and the trachea was extubated. The postoperative course and follow-up was unremarkable on both occasions. Plasma porphyrins at admission before the first operation and on the next day were less than 1 pddl. Porphyrin and complement assays before and after the second operation are shown in table 1.
Discussion
Hereditary coproporphyria may coexist with other types of porphyria, and hereditary angioedema with connective tissue disorders and polycystic ovary disease, but no other case of HC coexisting with HANE, has been reported.
Porphyrias are diseases that arise from enzymatic defects in the biosynthetic pathway of heme. Depending on the site of the defect in the metabolic pathway, different precursors may accumulate and lead to the manifestations of each specific type of porphyria. Hereditary coproporphyria is the least common of the acute bidity and mortality, can be precipitated by perioperative events, such as fasting, dehydration, hypothermia, surgical stress, and many anesthetic or nonanesthetic Prevention depends on avoidance of precipitating factors and drugs in susceptible individuals. Data regarding the capacity of drugs to induce porphyric crises are based on experimental studies, case reports, and clinical studies' and show that many commonly used drugs have been implicated as potential triggering agents.
In our perioperative management, we tried meticulously to avoid or treat perioperative factors that might precipitate an attack by providing adequate sedation, fluids, and carbohydrates, in addition to preventing hypothermia. The drugs selected were those for which there was ample evidence or convergence of data to support their safety. Most intravenous anesthetics and volatile agents either have been shown to be porphyrinogenic or have not been definitely cleared as "safe," according to previously published reports. We decided to use a propofol-nitrous oxide-oxygen-opioid relaxant technique for both procedures. Propofol is nonporphyrinogenic in animals4 and has been reported to be safe for i n d~c t i o n .~~" Nevertheless, Kasraie and Cousins' reported an HC attack occurrence after induction and maintenance with propofol, but four other potentially porphyrinogenic drugs were concomitantly used (erythromycin, metoclopramide, cocaine, and lidocaine). Bichel et al." also noticed increased urine porphyrins in an asymptomatic patient with variegate porphyria after propofol anesthesia. In our patient at the time of the second operation, elevated porphyrins already were seen initially in the preoperative, and also in the postoperative, urine sample. The postoperative levels were higher, but we cannot know if this is a result of random variation or porphyrinogenic activity secondary to drugs, or related to the fact that the preoperative measurement was based on a 14-h urine collection uersus a 24-11 collection postoperatively. It is possible that the postoperative values would not differ significantly from the preoperative ones, if the latter were extrapolated for a 24-h collection. Thus, we can speculate that our negative clinical and most laboratory findings are consistent with the safety of propofol for induction and maintenance and are in agreement with most other reAll other anesthetic drugs we used did not appear to port~.~JO be porphyrinogenic. Lidocaine, which has not been reported as safe,3." was avoided. For the first procedure, procaine was selected because of its documented safety,39" but it had an incomplete local anesthetic effect on the mucosa; therefore, bupivacaine, for which there is no evidence of p~rphyrinogenicity,~" was used for the second procedure. We also selected epinephrine for mucosal vasoconstriction because of the potential porphyrinogenicity of other vasoconstrictors.
Nonanesthetic porphyrinogenic drugs include anabolic steroids, such as the stanozolol," which the patient was receiving as prophylaxis against the severe HANE occurrences, but this did not seem to have any adverse consequences, consistent with the finding that porphyrinogenic drugs do not always precipitate occurrences, especially in the latent stages of the disease.' A possible dose-dependent drug-effect relation may be di~ease.'~ Levels were low preoperatively and remained low after both procedures. We do not have an explanation for the elevated urine porphyrins we noted the second time in the preoperative and postoperative samples: Whether stanozolol or other exposures produced this elevation is difficult to know. Complement factors were not measured in the first anesthetic, and in the second the preoperative C , measurement failed, but no suspicious clinical or biochemical evidence was found.
Acute porphyrias and HANE may be frequently underdiagnosed because many patients are asymptomatic in the latent phases. 14,15 Nevertheless, proper identification is of primary importance for an uneventful outcome after surgery and should be considered with a higher index of suspicion preoperatively in patients with suggestive presentation and family history.
another explanation. and can result from even minimally invasive procedures conducted in or near the Thus, tracheal intubation is contraindicated, but, if unavoidable, pharmacologic and replacement prophylaxis should be Anabolic steroids (stanozolol) and plasmin inhibitors decrease the incidence or reduce the severity of the attacks. Plasma levels of Cl-esterase inhibitor can be raised by fresh frozen plasma ( 2 -4 U), given within up to 24 h before surgery, or purified Cl-esterase inhibitor ~o n c e n t r a t e .~"~ In our patient, pretreatment included stanozolol and fresh frozen plasma. The airway had to be protected with an endotracheal tube because of the proximity of the surgical procedures, and nasal fiberoptic intubation was indicated because of the poor mouth opening. Nasotracheal intubation is more traumatic than the orotracheal, and more dangerous for patients with HANE," but, in our case, it did not precipitate any attack. The appropriate pretreatment and the significant variability regarding the angioedema attack threshold'* may be the explanations.
The documentation of the perianesthetic course as uneventful is based on negative clinical and laboratory data. Plasma porphyrins follow a characteristic pattern in HC and can be used for assessment of the activity of the
